Pfizer/BioNTech have announced that logistical issues pertaining to the temperature storage of the COVID-19 vaccine will delay the second shipment of the jab to Malta and eight other countries.
Spanish authorities reported receiving a message from Pizer’s manufacturing plant in Belgium indicating a one-day delivery delay due to “a problem in the loading and shipping process related to temperature control.”
“Due to a minor logistical issue, we have rescheduled a limited number of our deliveries. The logistical matter has been resolved and those deliveries are now being dispatched,” Pfizer said in a statement to Euronews.
Malta received its first batch of 10,000 doses on Saturday with the roll out beginning the next day. It was meant to receive the second consignment yesterday. However, it now seems that the batch will be arriving today.
The first person to receive the vaccine was nurse Rachel Grech, followed by a number of frontliners, including virologist Chris Barbara who claimed he “didn’t feel the needle.”
The Pfizer/BioNTech vaccine was the first to be approved by the European Medicines Agency (EMA) and the first to be rolled out in the EU. Malta could also distribute the Moderna and AstraZeneca vaccines when and if they are approved by the EMA.
Malta’s trade deficit widens to €4.7 billion as fuel imports surge
Imports climbed by nearly 12% to €9.98 billion, while exports grew by 11.1% to €5.25 billion
Malta’s median net income is below EU average
The broader European landscape reveals a clear economic split
Maltese innovators: Inconsistent enforcement, excessive bureaucracy deterring new ideas and tech
Participants during a workshop discussed both the progress made and the barriers that continue to affect innovation